US and EU plan bird flu vaccines for at-risk workers
Summary: The US and Europe are taking steps to acquire or manufacture H5N1 bird flu vaccines to protect at-risk individuals. US officials are preparing 4.8 million doses from CSL Seqirus. European health officials are in talks to acquire CSL's vaccine. Canada is discussing acquiring GSK's vaccine. The virus has spread to new mammal species, with the US reporting outbreaks in dairy cattle. Efforts aim to prevent a pandemic.
This is article metrics. Combined, they form a significance score, that indicates how important the news is on a scale from 0 to 10.
My algorithm scores 10,000 news articles daily, and creates a single significance-ordered list of news.
Read more about how I calculate significance, or see today's top ranked news on the main page:
See today's news rankings